Developer docs
API playgroundTry for free, no card

Search company profiles

SciMax

Full company profile

uuid000ch3j

Namestring
SciMax
Legal namestring
SciMax Global LLC
Company typeenum
Private
Founded yearstring
-
Descriptiontext

SciMax Global LLC is a Princeton, NJ-based SaaS provider focused exclusively on Scientific Communications and Medical Affairs technology for the pharmaceutical and life sciences industry. The company operates as a privately-held subsidiary of Techsol Corporation (doing business as Techsol Life Sciences). SciMax sells a unified, purpose-built cloud platform (SCIMAX) composed of six specialized modules — Medical Information (MI), Publication Planning (PUBS), Sponsored Trials Management (IIT), Grants Management, Expanded Access Management (EAP), and a Collaborative Engagement Portal (CP) — typically licensed as enterprise subscriptions with modular adoption.

The product architecture is built on .NET and Angular, runs on Oracle/MS SQL/MySQL databases, and deploys across AWS and Azure cloud infrastructure. On top of this platform the company has layered SCIMAX ARIN, an agentic AI offering launched in 2025 that combines generative AI with intelligent automation. SCIMAX ARIN powers 10+ specialized AI agents covering inquiry triage and case processing, adverse event/product complaint dispatch, content recommendation and response package composition, retrospective and predictive quality assurance, medical information chatbots, plain language summary generation, and journal/congress suggestion. The platform integrates with enterprise CRMs and Veeva Vault (PromoMats/MedComms), and SciMax maintains an unusually deep compliance posture — ISO 27001, ISO 13485, ISO 14155, ISO 9001, HIPAA, GDPR, and EU-US Data Privacy Framework — relevant to regulated life sciences buyers.

SciMax makes money through annual enterprise SaaS subscriptions (quote-based, modular pricing for SCIMAX MI, PUBS, GRANTS, CP and the AI agents) and through professional services for platform onboarding and Medical Affairs process consulting. Go-to-market is direct enterprise field sales targeting Top 50 pharmaceutical innovators, mid-sized firms, orphan drug and emerging biotech companies, medical information contact centers, and agencies. Demand generation is layered through industry event sponsorship (MAPS, ISMPP, DIA, World Patient Safety Congress), content marketing, paid search, and the proprietary SCIMAX Connect customer forum, which is scheduled for Boston in July 2026. Operations extend from Princeton, NJ to a delivery/technical hub in Hyderabad, India, with regulatory reach into the UK, Ireland, Germany, and South Korea for data processing. Named customers include JAMP Pharma Group, Knight Therapeutics, and an undisclosed rare-disease biopharma; MAPS is a Principal Partner with 15,000+ members from 280+ companies.

Short descriptiontext

SciMax Global LLC is a Princeton, NJ-based SaaS subsidiary of Techsol Corporation that sells a unified Medical Affairs platform (SCIMAX) — covering medical information, publications, grants, IIT, expanded access, and an agentic AI layer (ARIN) — to pharmaceutical, biotech, and rare disease companies globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical affairs software, pharmaceutical SaaS platform, medical information management, publication planning software, grants management solutions
Industry3 codes
PRIMARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAL
Regulatory Information Management (RIM) & Submission Publishing Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Medical Affairs SaaS Platform
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscriptions
TypeSubscription Recurring
Description

SciMax generates revenue primarily through SaaS platform subscriptions for their Medical Affairs software suite. The platform is offered as a cloud-based solution with configurable components, role-based access, and continuous enhancements. Pricing is likely based on enterprise agreements with modular components for different Medical Affairs functions.

scimaxglobal.com
2Professional Services
TypeProfessional Services
Description

Platform on-boarding and Medical Affairs process consulting services are offered, including enterprise software implementation, configuration, and domain expertise in strategizing, planning, and executing Medical Affairs projects.

scimaxglobal.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise SaaS Platform - Custom pricing based on organizational requirements
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Contact sales for pricing on SCIMAX MI, PUBS, GRANTS, CP platform and AI agents.

scimaxglobal.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SciMax Global provides a unified, cloud-based SaaS platform purpose-built for Medical Affairs operations in the pharmaceutical and life sciences industry. Its portfolio covers medical information inquiry management, publication planning, grants and expanded access program administration, and investigator-initiated trial management, augmented by the SCIMAX ARIN agentic AI layer for content generation, inquiry triage, and process automation. The company also offers implementation and Medical Affairs process consulting services alongside its software.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SciMax offers a unified SaaS platform for Medical Affairs with multiple specialized products and AI-powered agents. The core platform includes SCIMAX MI (Medical Inquiry Management), SCIMAX PUBS (Publication Planning), SCIMAX GRANTS, SCIMAX IIT (Investigator-Initiated Trials), SCIMAX EAP (Expanded Access), and SCIMAX CP (Collaborative Engagement Portal). These are complemented by SCIMAX ARIN, an agentic AI layer that powers multiple specialized AI agents including Inquiry Triage & Case Processing, Retrospective QA, Content Recommendation & Fulfilment, Smart Chatbots, Plain Language Generation, and Journal & Congress Suggester. Professional Services include platform on-boarding and Medical Affairs process consulting.

Product and service1 record
1SCIMAX MI (Medical Information)
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierPrincipal PartnerTypeStrategic or Co-development Partner
Description

MAPS is the premier non-profit global Medical Affairs organization with over 15,000+ members from 280+ companies globally. SciMax is a Principal Partner, collaborating to transform the Medical Affairs profession and increase its value to patients, HCPs, industry and society.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

PhactMI is a collaboration of pharmaceutical company Medical Information leaders dedicated to supporting healthcare professionals. SciMax is a Corporate Partner, working together to support quality patient care through medical information excellence.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISMPP is the global authority on ethical and effective communication of medical research with more than 2,600 members worldwide. SciMax participates in ISMPP events and academy programs.

4DIA (Drug Information Association)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

DIA is a global association that mobilizes life science professionals from across all areas of expertise. SciMax participates in DIA MedComms and Medical Affairs and Scientific Communications Forum events.

scimaxglobal.com
Strategic tierCoreTypeTechnology or Integration
Description

Techsol Life Sciences is the parent company of SciMax Global. Techsol provides data processing infrastructure and operates as the data controller for certain personal data processing activities. SciMax operates as the SaaS subsidiary focused on Medical Affairs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

IQVIA offers a broad portfolio across clinical, commercial, and Medical Affairs technology and services, including technology platforms for Medical Information and scientific communications. It is a broad incumbent rather than a Medical Affairs specialist, but competes for the same enterprise pharma wallet.

TypeDirect peer
Description

Envision is a long-established Medical Affairs and publications services + technology provider (including Datavision publications software) that competes with SciMax PUBS and adjacent medical communications offerings, particularly for pharma publication planning.

TypeDirect peer
Description

Complete HealthVizion (CHV) is a medical communications and scientific publications agency with proprietary technology, competing with SciMax PUBS and SCIMAX Platform Services in publications planning and scientific content delivery for pharma.

TypeDirect peer
Description

Veeva is the dominant life sciences CRM and content management vendor; its Vault PromoMats / MedComms products directly overlap with SciMax's SCIMAX MI and SCIMAX PUBS modules, and Veeva CRM competes in adjacent Medical Affairs workflows. It is the most relevant direct competitor given SciMax already integrates with Vault PromoMats/MedComms.

TypeEmerging player
Description

Trial Library is an emerging clinical-trial feasibility and site intelligence platform with partial overlap into Medical Affairs workflows. It is comparable as a niche SaaS targeting pharma operations teams but does not directly compete in Medical Information or publications.

TypeDirect peer
Description

Within3 provides a client management and HCP engagement platform widely used by Medical Affairs teams for advisory boards, MSL interactions, and insight management — overlapping with SciMax's Collaborative Engagement Portal (SCIMAX CP) and MSL lookup use cases.

TypeDirect peer
Description

Ashfield MedComms, now part of Inizio Medical, is a leading medical communications and publications agency serving pharma Medical Affairs, directly overlapping with SciMax PUBS and platform services for scientific content planning and dissemination.

TypeDirect peer
Description

MMS provides clinical and regulatory services with proprietary data and content technology serving pharma medical and regulatory affairs, partially overlapping with SciMax's regulatory-grade Medical Information and submissions-oriented offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SciMax

Medical Affairs SaaS Platformscimaxglobal.com

SciMax Global LLC is a Princeton, NJ-based SaaS subsidiary of Techsol Corporation that sells a unified Medical Affairs platform (SCIMAX) — covering medical information, publications, grants, IIT, expanded access, and an agentic AI layer (ARIN) — to pharmaceutical, biotech, and rare disease companies globally.

What SciMax does

SciMax Global LLC is a Princeton, NJ-based SaaS provider focused exclusively on Scientific Communications and Medical Affairs technology for the pharmaceutical and life sciences industry. The company operates as a privately-held subsidiary of Techsol Corporation (doing business as Techsol Life Sciences). SciMax sells a unified, purpose-built cloud platform (SCIMAX) composed of six specialized modules — Medical Information (MI), Publication Planning (PUBS), Sponsored Trials Management (IIT), Grants Management, Expanded Access Management (EAP), and a Collaborative Engagement Portal (CP) — typically licensed as enterprise subscriptions with modular adoption.

The product architecture is built on .NET and Angular, runs on Oracle/MS SQL/MySQL databases, and deploys across AWS and Azure cloud infrastructure. On top of this platform the company has layered SCIMAX ARIN, an agentic AI offering launched in 2025 that combines generative AI with intelligent automation. SCIMAX ARIN powers 10+ specialized AI agents covering inquiry triage and case processing, adverse event/product complaint dispatch, content recommendation and response package composition, retrospective and predictive quality assurance, medical information chatbots, plain language summary generation, and journal/congress suggestion. The platform integrates with enterprise CRMs and Veeva Vault (PromoMats/MedComms), and SciMax maintains an unusually deep compliance posture — ISO 27001, ISO 13485, ISO 14155, ISO 9001, HIPAA, GDPR, and EU-US Data Privacy Framework — relevant to regulated life sciences buyers.

SciMax makes money through annual enterprise SaaS subscriptions (quote-based, modular pricing for SCIMAX MI, PUBS, GRANTS, CP and the AI agents) and through professional services for platform onboarding and Medical Affairs process consulting. Go-to-market is direct enterprise field sales targeting Top 50 pharmaceutical innovators, mid-sized firms, orphan drug and emerging biotech companies, medical information contact centers, and agencies. Demand generation is layered through industry event sponsorship (MAPS, ISMPP, DIA, World Patient Safety Congress), content marketing, paid search, and the proprietary SCIMAX Connect customer forum, which is scheduled for Boston in July 2026. Operations extend from Princeton, NJ to a delivery/technical hub in Hyderabad, India, with regulatory reach into the UK, Ireland, Germany, and South Korea for data processing. Named customers include JAMP Pharma Group, Knight Therapeutics, and an undisclosed rare-disease biopharma; MAPS is a Principal Partner with 15,000+ members from 280+ companies.

SciMax firmographics

Firmographics
Name
SciMax
Legal name
SciMax Global LLC
Website
https://scimaxglobal.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
SciMax Global LLC is a Princeton, NJ-based SaaS subsidiary of Techsol Corporation that sells a unified Medical Affairs platform (SCIMAX) — covering medical information, publications, grants, IIT, expanded access, and an agentic AI layer (ARIN) — to pharmaceutical, biotech, and rare disease companies globally.
Ownership category
akta.pro rank

SciMax industry classification

Industry
Product category
Medical Affairs SaaS Platform
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAL
Regulatory Information Management (RIM) & Submission Publishing Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Medical affairs software
  • Pharmaceutical SaaS platform
  • Medical information management
  • Publication planning software
  • Grants management solutions

Where SciMax is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SciMax business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscriptions: SciMax generates revenue primarily through SaaS platform subscriptions for their Medical Affairs software suite. The platform is offered as a cloud-based solution with configurable components, role-based access, and continuous enhancements. Pricing is likely based on enterprise agreements with modular components for different Medical Affairs functions.
  2. Professional Services: Platform on-boarding and Medical Affairs process consulting services are offered, including enterprise software implementation, configuration, and domain expertise in strategizing, planning, and executing Medical Affairs projects.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS Platform - Custom pricing based on organizational requirements

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

SciMax product offering

Product offering

Core offering

SciMax Global provides a unified, cloud-based SaaS platform purpose-built for Medical Affairs operations in the pharmaceutical and life sciences industry. Its portfolio covers medical information inquiry management, publication planning, grants and expanded access program administration, and investigator-initiated trial management, augmented by the SCIMAX ARIN agentic AI layer for content generation, inquiry triage, and process automation. The company also offers implementation and Medical Affairs process consulting services alongside its software.

Product overview

SciMax offers a unified SaaS platform for Medical Affairs with multiple specialized products and AI-powered agents. The core platform includes SCIMAX MI (Medical Inquiry Management), SCIMAX PUBS (Publication Planning), SCIMAX GRANTS, SCIMAX IIT (Investigator-Initiated Trials), SCIMAX EAP (Expanded Access), and SCIMAX CP (Collaborative Engagement Portal). These are complemented by SCIMAX ARIN, an agentic AI layer that powers multiple specialized AI agents including Inquiry Triage & Case Processing, Retrospective QA, Content Recommendation & Fulfilment, Smart Chatbots, Plain Language Generation, and Journal & Congress Suggester. Professional Services include platform on-boarding and Medical Affairs process consulting.

Differentiator

Problem solved

Functional benefit

Products and services

  • SCIMAX MI (Medical Information)

Companies that use SciMax

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

SciMax technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature11 records

SciMax partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered principal partner and core.

  • MAPS (Medical Affairs Professional Society)principal partnerStrategic or Co-development PartnerMAPS is the premier non-profit global Medical Affairs organization with over 15,000+ members from 280+ companies globally. SciMax is a Principal Partner, collaborating to transform the Medical Affairs profession and increase its value to patients, HCPs, industry and society.
  • PhactMIcoreStrategic or Co-development PartnerPhactMI is a collaboration of pharmaceutical company Medical Information leaders dedicated to supporting healthcare professionals. SciMax is a Corporate Partner, working together to support quality patient care through medical information excellence.
  • ISMPP (International Society for Medical Publication Professionals)coreStrategic or Co-development PartnerISMPP is the global authority on ethical and effective communication of medical research with more than 2,600 members worldwide. SciMax participates in ISMPP events and academy programs.
  • DIA (Drug Information Association)coreStrategic or Co-development PartnerDIA is a global association that mobilizes life science professionals from across all areas of expertise. SciMax participates in DIA MedComms and Medical Affairs and Scientific Communications Forum events.
  • Techsol Life Sciences (Parent Company)coreTechnology or IntegrationTechsol Life Sciences is the parent company of SciMax Global. Techsol provides data processing infrastructure and operates as the data controller for certain personal data processing activities. SciMax operates as the SaaS subsidiary focused on Medical Affairs.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

SciMax competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA offers a broad portfolio across clinical, commercial, and Medical Affairs technology and services, including technology platforms for Medical Information and scientific communications. It is a broad incumbent rather than a Medical Affairs specialist, but competes for the same enterprise pharma wallet.

Direct peers

  • Envision Pharma Group: Envision is a long-established Medical Affairs and publications services + technology provider (including Datavision publications software) that competes with SciMax PUBS and adjacent medical communications offerings, particularly for pharma publication planning.
  • Complete HealthVizion: Complete HealthVizion (CHV) is a medical communications and scientific publications agency with proprietary technology, competing with SciMax PUBS and SCIMAX Platform Services in publications planning and scientific content delivery for pharma.
  • Veeva Systems: Veeva is the dominant life sciences CRM and content management vendor; its Vault PromoMats / MedComms products directly overlap with SciMax's SCIMAX MI and SCIMAX PUBS modules, and Veeva CRM competes in adjacent Medical Affairs workflows. It is the most relevant direct competitor given SciMax already integrates with Vault PromoMats/MedComms.
  • Within3: Within3 provides a client management and HCP engagement platform widely used by Medical Affairs teams for advisory boards, MSL interactions, and insight management — overlapping with SciMax's Collaborative Engagement Portal (SCIMAX CP) and MSL lookup use cases.
  • Ashfield MedComms (Inizio Medical): Ashfield MedComms, now part of Inizio Medical, is a leading medical communications and publications agency serving pharma Medical Affairs, directly overlapping with SciMax PUBS and platform services for scientific content planning and dissemination.
  • MMS (Medical Marketing Solutions): MMS provides clinical and regulatory services with proprietary data and content technology serving pharma medical and regulatory affairs, partially overlapping with SciMax's regulatory-grade Medical Information and submissions-oriented offerings.

Emerging players

  • Trial Library: Trial Library is an emerging clinical-trial feasibility and site intelligence platform with partial overlap into Medical Affairs workflows. It is comparable as a niche SaaS targeting pharma operations teams but does not directly compete in Medical Information or publications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

SciMax social profiles

Digital presence

SciMax compliance and trust

Trust signal

Compliance7 records

SciMax financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SciMax leadership team

Management profile

Number of profiles

Profiles7 records

SciMax funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SciMax M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SciMax

What does SciMax do?

SciMax Global provides a unified, cloud-based SaaS platform purpose-built for Medical Affairs operations in the pharmaceutical and life sciences industry. Its portfolio covers medical information inquiry management, publication planning, grants and expanded access program administration, and investigator-initiated trial management, augmented by the SCIMAX ARIN agentic AI layer for content generation, inquiry triage, and process automation. The company also offers implementation and Medical Affairs process consulting services alongside its software.

Is SciMax a public or private company?

SciMax is a private company. It is classified as corporate owned and is currently operating.

When was SciMax founded?

SciMax was founded in -1. It employs 11 to 50 people.

Where is SciMax based?

SciMax is headquartered in Princeton, United States, in the North America region.

How does SciMax make money?

Two revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are professional Services.

Who are SciMax's main competitors?

IQVIA is listed as a broad incumbent. Direct peers are Envision Pharma Group, Complete HealthVizion, Veeva Systems, Within3, Ashfield MedComms (Inizio Medical) and MMS (Medical Marketing Solutions). Trial Library is listed as an emerging player.

Does SciMax have an API?

No public API is recorded for SciMax.

What industry is SciMax in?

SciMax's product category is Medical Affairs SaaS Platform. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals